ArticleCancer gene therapy2015

An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.

Y Kostova et al.PubMed ↗Publisher ↗

No numbers read from the abstract.